ArticleFrontiers in public health2025
The trend analysis of HIV and other sexually transmitted infections among women of childbearing aged 15 to 49 years from 1990 to 2021 and its forecasting from 2022 to 2030.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The adiponectin-depression nexus: a brief review of mechanisms and therapeutic opportunities.Metabolic brain disease · 2026Review
- Divergent Burden Profiles of HIV/AIDS and Other Sexually Transmitted Infections Among Women of Child-Bearing Age, 1990-2021.International journal of women's health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: HIV and other sexually transmitted infections (STIs) among women of childbearing age need in-depth research because of the physiological characteristics and their disadvantages in obtaining equal health rights. We intend to present the burden of disease worldwide from 1990 to 2021 using data from the Global Burden of Disease (GBD) study and forecast the DALYs from 2022 to 2030. Methods: Using the 2021 GBD study, we researched the average annual percentage change (AAPC) of HIV and other STIs in incidence, prevalence, disability-adjusted life years (DALYs) rates for women of childbearing age aged 15 to 49 years across different age groups, sociodemographic index (SDI) regions, and nations. We used statistical Autoregressive Integrated Moving Average (ARIMA) models to forecast. Results: In 2021, there were 670,804 new AIDS cases in women of childbearing age globally, with a decrease in age-standardized incidence rate (AAPC -1.94, -2.21 to -1.67) and an increase in age-standardized DALYs rate (AAPC 1.67, 1.20 to 2.14) from 1990 to 2021. There were 286,514,651 new other STIst cases with an increase in age-standardized incidence rate (AAPC 0.12, 0.09 to 0.14) and a decrease in age-standardized DALYs rate (AAPC -0.15, -0.18 to -0.11). The largest increase in age-standardized incidence rate of HIV occurred in Oceania from 1990 to 2021. The SDI trends were the opposite of age-standardized incidence rate and age-standardized DALYs rate for HIV and other STIs among women of childbearingage. The STI and HIV epidemics are interdependent. Women aged 30-34 years were the group with the highest incidence and DALY rates. Trichomoniasis and chlamydia account for the majority of cases of other STIs. The DALYs rate of HIV showed a downward trend, and the DALYs rate of other STIs showed an upward trend from 2022 to 2030. Conclusion: Our study investigated the status of HIV and other STIs in women of childbearing age. The DALYs rate of HIV increased. The incidence rate of other STIs raised and the number of cases was so high that the harm could not be ignored. All sectors of the global community should pay attention to the prevention and control of STIs among women of childbearing age.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.